EchoIQ Ltd
Echo IQ Limited is an Australia-based company.
The business
Echo IQ Limited is an Australia-based company. It is an artificial intelligence (AI) and medical technology company. The Company uses AI-driven technology and proprietary software to improve decision-making in cardiology. The principal activity of the Company is the development of AI software that aids in predicting Aortic Stenosis heart condition. The Company's EchoSolv platform harnesses AI-driven analysis of echocardiographic data to assist clinicians in detecting aortic stenosis and other conditions. Its EchoSolv product allows users to assess echocardiographic studies against diagnostic guidelines for structural heart conditions. EchoSolv automatically identifies patients at risk of structural heart disease. EchoSolv improves the standard clinical workflow associated with diagnosis and treatment. The Company's subsidiaries include HWH Software Pty Ltd, Echo IQ Global Pty Ltd and Echo IQ Incorporated.
Small Caps Research
No research on EchoIQ Ltd yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise EIQ based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
Echo IQ Reports Strong US Performance of EchoSolv AS Platform Ahead of Regulatory Clearance
Perth-based medical technology company Echo IQ (ASX: EIQ) has reported strong operational momentum from its EchoSolv AS platform in the US market, with a 153% increase in echocardiograms over the three months to September. The performance has come about through extensive engagement with US hospital groups, which have integrated the technology into their operations, resulting in the […]
Echo IQ Secures Echosolv Reseller Agreement with SARC MedIQ to Broaden US Uptake
Echo IQ (ASX: EIQ) will expand the use of its EchoSolv AI software through a US network of hospitals and cardiology practices after locking in a reseller agreement with provider SARC MedIQ. Under the terms, EchoSolv will be utilised by more than 1,500 physicians at over 300 healthcare facilities and clinics within SARC’s network in […]
Echo IQ signs partnership agreement with ScImage to distribute EchoSolv AI cardiac software
Medical technology company Echo IQ (ASX: EIQ) has secured a partnership agreement with US-based ScImage Inc that will make its EchoSolv artificial intelligence (AI) medical software available to medical practitioners within the next three months. The system aims to provide medical practitioners with access to high-quality, automated and AI-backed echocardiography assessments to assist in the […]
Echo IQ trial shows EchoSolv screening platform improves diagnosis of severe aortic stenosis
A flagship clinical trial of Echo IQ’s (ASX: EIQ) EchoSolv artificial intelligence (AI) medical software technology has identified 72% more patients with severe aortic stenosis than human diagnosis alone. The trial was designed to test the effectiveness of the screening platform in identifying patients at risk of dying from the condition, which is reported to […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.